Mar 14, 2019 04:01PM
Mar 14, 2019 04:01PM
Feb 19, 2019 08:13AM
Feb 19, 2019 08:00AM
Feb 11, 2019 08:04AM
Feb 11, 2019 08:00AM
Feb 11, 2019 08:00AM Allakos Announces Positive Phase 2 Results for AK002 in Patients with Xolair Refractory Chronic Spontaneous Urticaria and Provides Additional Data from Chronic Urticaria Study Cohorts
Feb 4, 2019 08:00AM
Jan 29, 2019 08:06AM
Jan 29, 2019 08:00AM
Jan 7, 2019 08:11AM
Jan 7, 2019 08:00AM
Dec 18, 2018 07:30AM
Nov 8, 2018 04:01PM Allakos Announces Clinical Update and Third Quarter 2018 Financial Results
Oct 8, 2018 08:13AM
Oct 8, 2018 08:00AM
Aug 29, 2018 04:01PM
Jul 24, 2018 08:00AM
Jul 19, 2018 12:16PM
Jul 19, 2018 07:07AM
Jul 19, 2018 07:00AM Allakos Announces Pricing of Initial Public Offering

118,853 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All